222 related articles for article (PubMed ID: 29797312)
1. A prospective observational study of pigmented naevi changes in psoriasis patients on biologic therapy.
Choi SD; D'Souza MI; Menzies SW; Weninger W
Australas J Dermatol; 2019 Feb; 60(1):e14-e19. PubMed ID: 29797312
[TBL] [Abstract][Full Text] [Related]
2. Melanocytic nevus count and dermoscopic features do not differ in psoriatic patients undergoing biological agent versus conventional drug therapy.
Pirmit S; Onsun N; Su O; Ozkaya DB
G Ital Dermatol Venereol; 2017 Apr; 152(2):126-131. PubMed ID: 28166613
[TBL] [Abstract][Full Text] [Related]
3. 'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.
Koh U; Janda M; Aitken JF; Duffy DL; Menzies S; Sturm RA; Schaider H; Betz-Stablein B; Prow T; Soyer HP; Green AC
BMJ Open; 2018 Sep; 8(9):e025857. PubMed ID: 30232117
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
Bauer J; Blum A; Strohhäcker U; Garbe C
Br J Dermatol; 2005 Jan; 152(1):87-92. PubMed ID: 15656806
[TBL] [Abstract][Full Text] [Related]
5. Changes in common melanocytic naevi after intense sun exposure: digital dermoscopic study with a 1-year follow-up.
Dobrosavljevic D; Brasanac D; Apostolovic M; Medenica L
Clin Exp Dermatol; 2009 Aug; 34(6):672-8. PubMed ID: 19183403
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dynamic dermoscopic features of melanoma and benign naevi by sequential digital dermoscopic imaging and total body photography in a high-risk Australian cohort.
Nguyen J; Doolan BJ; Pan Y; Vestergaard T; Paul E; McLean C; Haskett M; Kelly J; Mar V; Chamberlain A
Australas J Dermatol; 2023 Feb; 64(1):67-79. PubMed ID: 36652275
[TBL] [Abstract][Full Text] [Related]
7. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi.
Zalaudek I; Grinschgl S; Argenziano G; Marghoob AA; Blum A; Richtig E; Wolf IH; Fink-Puches R; Kerl H; Soyer HP; Hofmann-Wellenhof R
Br J Dermatol; 2006 Feb; 154(2):299-304. PubMed ID: 16433800
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
Medina-Gil C; Dehesa L; Vega A; Kerdel F
Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
[TBL] [Abstract][Full Text] [Related]
9. Super-high magnification dermoscopy can aid the differential diagnosis between melanoma and atypical naevi.
Cinotti E; Tognetti L; Campoli M; Liso F; Cicigoi A; Cartocci A; Rossi R; Rubegni P; Perrot JL
Clin Exp Dermatol; 2021 Oct; 46(7):1216-1222. PubMed ID: 33486758
[TBL] [Abstract][Full Text] [Related]
10. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
Ross C; Marshman G; Grillo M; Stanford T
Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi?
Balato N; Di Costanzo L; Balato A; Patruno C; Scalvenzi M; Ayala F
Br J Dermatol; 2011 Jun; 164(6):1262-70. PubMed ID: 21574971
[TBL] [Abstract][Full Text] [Related]
12. Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy.
Kilinc Karaarslan I; Teban L; Dawid M; Tanew A; Kittler H
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):526-31. PubMed ID: 17373982
[TBL] [Abstract][Full Text] [Related]
13. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
14. Melanoma risk stratification of individuals with a high-risk naevus phenotype - A pilot study.
Rishpon A; Navarrete-Dechent C; Marghoob AA; Dusza SW; Isman G; Kose K; Halpern AC; Marchetti MA
Australas J Dermatol; 2019 Nov; 60(4):e292-e297. PubMed ID: 30941757
[TBL] [Abstract][Full Text] [Related]
15. Dermoscopic changes in melanocytic naevi in children during digital follow-up.
Fortina AB; Zattra E; Bernardini B; Alaibac M; Peserico A
Acta Derm Venereol; 2012 Jul; 92(4):427-9. PubMed ID: 22367216
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
[TBL] [Abstract][Full Text] [Related]
18. First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq.
Assan F; Tubach F; Arlegui H; Viguier M; Beylot-Barry M; Dupuy A; Beneton N; Joly P; Jullien D; Mahé E; Paul C; Richard MA; Bachelez H; Giboin C; Chosidow O; Sbidian E;
Dermatology; 2021; 237(3):338-346. PubMed ID: 33535213
[TBL] [Abstract][Full Text] [Related]
19. Dermoscopic features of congenital acral melanocytic naevi in children: a prospective comparative and follow-up study.
Chuah SY; Tsilika K; Chiaverini C; Fontas E; Ortonne JP; Lacour JP; Bahadoran P
Br J Dermatol; 2015 Jan; 172(1):88-93. PubMed ID: 24931364
[TBL] [Abstract][Full Text] [Related]
20. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
Baniandrés O; Rodríguez-Soria VJ; Romero-Jiménez RM; Suárez R
Actas Dermosifiliogr; 2015 Sep; 106(7):569-77. PubMed ID: 25935194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
